Grifols (GRFS) Accounts Payables (2010 - 2025)

Grifols (GRFS) reported Accounts Payables of $1.3 billion for Q4 2025, up 8.45% on a YoY basis from $1.2 billion in Q4 2024, and up 8.45% quarter-over-quarter from $1.2 billion in Q4 2024.

Grifols (GRFS) Accounts Payables (2010 - 2025) Analysis & Trends

Grifols has reported Accounts Payables for 16 years, with the latest figure at $1.3 billion in Q4 2025.

  • For the quarter ending Q4 2025, Accounts Payables rose 8.45% year-over-year to $1.3 billion; the trailing twelve-month figure through Dec 2025 stood at $1.3 billion (up 8.45% YoY), and the FY2025 full-year result was $1.3 billion, up 8.45% from the prior year.
  • Accounts Payables for Q4 2025 stood at $1.3 billion, up from $1.2 billion in the prior quarter.
  • The five-year high for Accounts Payables was $1.3 billion in Q4 2025, with the low at $719.5 million in Q4 2021.
  • Historically, Accounts Payables has averaged $982.1 million across 5 years, with a median of $885.4 million in 2023.
  • Annual changes were most pronounced in 2021 — Accounts Payables climbed 0.31% — and 2024, when it jumped 35.53%.
  • Grifols' Accounts Payables stood at $719.5 million in 2021, then climbed by 11.73% to $803.9 million in 2022, then advanced by 10.14% to $885.4 million in 2023, then surged by 35.53% to $1.2 billion in 2024, then gained by 8.45% to $1.3 billion in 2025.
  • The last three Accounts Payables figures came in at $1.3 billion (Q4 2025), $1.2 billion (Q4 2024), and $885.4 million (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -19.33 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 5.03 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 10.46 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 33.77 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 3.86 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 2.94 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 645.00 Mn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 4.51 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 4.23 Bn
10 Grifols 6.05 Bn 5.09 Bn - 1.30 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.30 Bn
Dec 31, 2024 1.20 Bn
Dec 31, 2023 885.45 Mn
Dec 31, 2022 803.92 Mn
Dec 31, 2021 719.55 Mn
Dec 31, 2020 717.30 Mn
Dec 31, 2019 644.08 Mn
Dec 31, 2018 641.33 Mn
Jun 30, 2018 509.83 Mn
Dec 31, 2017 498.17 Mn
Jun 30, 2017 434.13 Mn
Dec 31, 2016 660.71 Mn
Sep 30, 2016 436.40 Mn
Jun 30, 2016 452.56 Mn
Dec 31, 2015 449.39 Mn
Sep 30, 2015 391.32 Mn
Jun 30, 2015 406,464.33
Mar 31, 2015 430.85 Mn
Dec 31, 2014 549.47 Mn
Dec 31, 2013 372.42 Mn